EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Prospective randomised double‐blind trial: holmium laser lithotripsy with vs without Moses™ 2.0

Kimberly A Maciolek iD, Naren Nimmagadda iD, Aaron X Lee iD, Amy M Reed, Ryan S Hsi iD, Tatsuki Koyama iD, Connor M Forbes iD, Matthew S Lee iD, Cyrus Chehroudi iD, Ezra J Margolin iD, Ben H Chew iD, Seth K Bechis und 8 weitere

BJU International · 2026-12 · 138 (6) · 1104-1114

DOI: 10.1111/bju.70446 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift BJU International, online erschienen am 13.09.2026. Verfasst von Kimberly A Maciolek und 19 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University Medical Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Lithotripsy, Laser, Kidney Calculi, Lasers, Solid-State. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Endourology Disease Group for Excellence (EDGE), Lumenis, Enhancing Diversity in Graduate Education Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the effect of Moses™ 2.0 (Lumenis Be Ltd., Yokneam Illit, Israel; Boston Scientific, Marlborough, MA, USA) for lithotripsy of renal stones of 8–20 mm in diameter on operative time, surgeon workload, and retropulsion. Subjects/Patients and Methods In our multicentre, randomised, double‐blind clinical trial, patients were randomised 1:1 to standard or Moses 2.0 laser lithotripsy and stratified by stone size. Patients and surgeons were blinded to laser modality. Primary outcomes were total operative time as well as surgeon workload assessed by the National Aeronautics and Space Administration‐Task Load Index (NASA‐TLX). Secondary outcomes were stone retropulsion evaluated by blinded video review and postoperative clinical outcomes. Linear regression modelling was used for analysis.

Results

A total of 153 patients (79 Standard, 74 Moses 2.0) with similar clinical, stone, and operative characteristics were evaluated. There was no significant difference in operative times between the Standard and Moses 2.0 groups ( P = 0.73). Moses 2.0 was associated with lower effort, frustration, mental, physical, and temporal workload, as well as higher rated overall performance compared to the standard laser. Video review demonstrated no difference in rates of retropulsion ( P = 0.13). Complication rates (Standard: 13%; Moses 2.0: 10%) and stone‐free rates (Standard: 51%; Moses: 2.0 55%) were comparable.

Conclusion

Our study evaluated the impact of Moses 2.0 technology on high‐powered renal stone dusting, constituting the largest double‐blind trial of its kind to date. There was insufficient evidence to suggest any difference in operative times or clinical outcomes when using Moses 2.0 compared to standard laser lithotripsy. Moses 2.0 was associated with reduced surgeon workload, which has implicit impact on surgeon wellness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lithotripsy, LaserKidney CalculiLasers, Solid-StateHumansDouble-Blind MethodProspective StudiesMaleFemaleOperative TimeMiddle AgedTreatment OutcomeAdultWorkloadAged

Stichwörter der Autor:innen

adultkidney calculilaser lithotripsysolid‐state lasersureteroscopyworkload

Autor:innen und Institutionen

  • Vanderbilt University Medical Center, Nashville, TN, USA.
  • University of Virginia, Charlottesville, VA, USA.
  • Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Brook Army Medical Center, San Antonio, TX, USA.
  • University of California Irvine, Irvine, CA, USA.
  • University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Kimberly A Maciolek, Naren Nimmagadda, Aaron X Lee, Ryan S Hsi, Tatsuki Koyama, Connor M Forbes, Matthew S Lee, Cyrus Chehroudi, Ezra J Margolin, Ben H Chew, Ojas Shah, Nicole L Miller

Förderung

  • Endourology Disease Group for Excellence (EDGE)
  • Lumenis
  • Enhancing Diversity in Graduate Education Program

Zitieren

APA

Maciolek, K. A., Nimmagadda, N., Lee, A. X., Reed, A. M., Hsi, R. S., Koyama, T., Forbes, C. M., Lee, M. S., Chehroudi, C., Margolin, E. J., Chew, B. H., Bechis, S. K., Humphreys, M. R., Lipkin, M. E., Monga, M., Shah, O., Stern, K. L., Sur, R. L., Sivalingam, S., & Miller, N. L. (2026). Prospective randomised double‐blind trial: holmium laser lithotripsy with vs without Moses™ 2.0. BJU International, 138(6), 1104-1114. https://doi.org/10.1111/bju.70446

Vancouver

Maciolek KA, Nimmagadda N, Lee AX, Reed AM, Hsi RS, Koyama T, et al. Prospective randomised double‐blind trial: holmium laser lithotripsy with vs without Moses™ 2.0. BJU International. 2026;138(6):1104-1114. doi:10.1111/bju.70446

BibTeX
@article{Maciolek2026,
  author = {Maciolek, Kimberly A and Nimmagadda, Naren and Lee, Aaron X and Reed, Amy M and Hsi, Ryan S and Koyama, Tatsuki and Forbes, Connor M and Lee, Matthew S and Chehroudi, Cyrus and Margolin, Ezra J and Chew, Ben H and Bechis, Seth K and Humphreys, Mitchell R and Lipkin, Michael E and Monga, Manoj and Shah, Ojas and Stern, Karen L and Sur, Roger L and Sivalingam, Sri and Miller, Nicole L},
  title = {Prospective randomised double‐blind trial: holmium laser lithotripsy with vs without Moses™ 2.0},
  journal = {BJU International},
  year = {2026},
  volume = {138},
  number = {6},
  pages = {1104--1114},
  doi = {10.1111/bju.70446}
}
Kostenlos starten →